CIBC Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,002
| Closed | -$202K | – | 1136 |
|
|
2023
Q4 | $202K | Buy |
+4,002
| New | +$202K | ﹤0.01% | 996 |
|
|
2022
Q4 | – | Sell |
-5,203
| Closed | -$230K | – | 1159 |
|
|
2022
Q3 | $230K | Buy |
+5,203
| New | +$230K | ﹤0.01% | 1005 |
|
|
2022
Q2 | – | Sell |
-5,583
| Closed | -$207K | – | 1375 |
|
|
2022
Q1 | $207K | Buy |
+5,583
| New | +$207K | ﹤0.01% | 1362 |
|
|
2021
Q3 | – | Sell |
-5,140
| Closed | -$205K | – | 1477 |
|
|
2021
Q2 | $205K | Hold |
5,140
| – | – | ﹤0.01% | 1275 |
|
|
2021
Q1 | $231K | Sell |
5,140
-106
| -2% | -$4.76K | ﹤0.01% | 1140 |
|
|
2020
Q4 | $297K | Hold |
5,246
| – | – | ﹤0.01% | 906 |
|
|
2020
Q3 | $249K | Buy |
5,246
+130
| +3% | +$6.17K | ﹤0.01% | 908 |
|
|
2020
Q2 | $302K | Hold |
5,116
| – | – | ﹤0.01% | 799 |
|
|
2020
Q1 | $242K | Hold |
5,116
| – | – | ﹤0.01% | 799 |
|
|
2019
Q4 | $309K | Buy |
5,116
+613
| +14% | +$37K | ﹤0.01% | 865 |
|
|
2019
Q3 | $270K | Hold |
4,503
| – | – | ﹤0.01% | 884 |
|
|
2019
Q2 | $289K | Hold |
4,503
| – | – | ﹤0.01% | 870 |
|
|
2019
Q1 | $366K | Hold |
4,503
| – | – | ﹤0.01% | 784 |
|
|
2018
Q4 | $243K | Hold |
4,503
| – | – | ﹤0.01% | 856 |
|
|
2018
Q3 | $232K | Buy |
+4,503
| New | +$232K | ﹤0.01% | 980 |
|
|
2018
Q1 | – | Sell |
-4,190
| Closed | -$211K | – | 1073 |
|
|
2017
Q4 | $211K | Hold |
4,190
| – | – | ﹤0.01% | 986 |
|
|
2017
Q3 | $212K | Buy |
+4,190
| New | +$212K | ﹤0.01% | 939 |
|
|
2016
Q1 | – | Sell |
-3,637
| Closed | -$225K | – | 955 |
|
|
2015
Q4 | $225K | Buy |
+3,637
| New | +$225K | ﹤0.01% | 823 |
|
|
2015
Q3 | – | Sell |
-3,637
| Closed | -$209K | – | 956 |
|
|
2015
Q2 | $209K | Buy |
3,637
+117
| +3% | +$6.72K | ﹤0.01% | 898 |
|
|
2015
Q1 | $224K | Buy |
3,520
+210
| +6% | +$13.4K | ﹤0.01% | 870 |
|
|
2014
Q4 | $204K | Buy |
+3,310
| New | +$204K | ﹤0.01% | 879 |
|